Österreich » News & Media » Pressemitteilungen



Stallergenes and Shionogi sign exclusive partnership agreements


Antony, France (September 6, 2010). Stallergenes S.A. has announced today the signing of exclusive partnership agreements with Shionogi & Co., Ltd. for two sublingual allergen immunotherapy tablet products resulting from the Stalair® program: Actair® house dust mite tablets and Japanese cedar pollen tablets.